A 24-Week, Multicenter, Exploratory, Two Arm Study to Assess the Effect of Dimethyl Fumarate on Immune-Modulatory Action on T cells in Patients with Relapsing Remitting Multiple Sclerosis (DIMAT-MS)


Beteiligte Wissenschaftler:
Dipl.-Stat. M. Eveslage

Studienleitung:
PD Dr. med. Luisa Klotz